Physician

Abhishek Seth, MD

According to 2025 Medicare claims, Abhishek Seth, MD (NPI: 1578903795) practices hematology/oncology in the State College, PA market, with the plurality of this provider's patient population coming from Centre, PA. This provider's primary affiliated billing organization is CENTRE COUNTY CANCER CENTER (NPI: 1477891711; TIN: 800866636) and primary practice location at 16803-6702.

Seth's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 424 traditional Medicare patients, billed 176,700 HCPCS/CPT codes, and received $2,962,536 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,524 prescription claims across 213 beneficiaries totaling $2,781,936 in drug costs, led by Ibrance (Palbociclib). 2022 DME data shows 24 claims. Open Payments data shows 41 records totaling $1,133. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $13,551 to $2,962,536. Similarly, Part D prescription costs have moved sharply higher in recent years, from $47,623 to $2,781,936. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	69	189	$13,551
2020	403	30,448	$771,736
2021	415	54,453	$1,025,636
2022	263	21,307	$400,735
2023	152	18,334	$261,258
2024	424	176,700	$2,962,536

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	41	552	$47,623
2016	44	434	$24,844
2017	21	52	$6,390
2018	N/R	14	$1,896
2019	25	79	$41,119
2020	104	362	$543,703
2021	146	851	$1,335,969
2022	123	581	$670,254
2023	47	127	$90,449
2024	213	1,524	$2,781,936

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	16	$4
2021	N/R	11	$954
2022	N/R	24	$1,449
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	118	397	$140
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	151	236	$99
96413	Administration of chemotherapy into vein, 1 hour or less	87	369	$96
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	72	143	$47
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	163	335	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	25	700	$385,771
Xtandi	Enzalutamide	23	690	$320,180
Revlimid	Lenalidomide	21	518	$292,464
Abiraterone Acetate	Abiraterone Acetate	124	3,780	$223,545
Zejula	Niraparib Tosylate	12	360	$199,467

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	41	$1,133	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abhishek Seth, MD?

Tedicare shows public-source Medicare data for Abhishek Seth, MD (NPI 1578903795), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhishek Seth, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abhishek Seth, MD?

Abhishek Seth, MD is linked to CENTRE COUNTY CANCER CENTER (billing NPI 1477891711) in the available physician profile data.

Does Abhishek Seth, MD have Open Payments data?

Abhishek Seth, MD has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.